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Dr Vidap
doi:10.1016/j.jtcvs.2007.09.007bjective: We sought to identify and characterize a subgroup of patients with
ypoplastic left heart syndrome who might be at higher risk for stage I failure.
ethods: From January 2001 through December 2006, all patients with hypoplastic
eft heart syndrome who underwent stage I palliation at Children’s Hospital Boston
ere retrospectively reviewed. The subgroup with the mitral stenosis–aortic atresia
ariant was studied separately. We evaluated preoperative echocardiographic data,
perative characteristics, and postoperative factors associated with death or the need
or transplantation. The Kaplan–Meier method was used to assess survival.
esults: Thirty-eight (23%) of 165 patients had mitral stenosis–aortic atresia. Hospital
ortality or need for transplantation for patients with mitral stenosis–aortic atresia was
ignificantly higher than for other anatomic subgroups (29% vs 7.9%, P  .002). Left
entricle–subepicardial coronary artery communications were present in 20 (53%)
atients with mitral stenosis–aortic atresia and were associated with a significantly
igher hospital mortality (50% vs 6%, P  .004). No difference in outcome was
emonstrated between different sources of pulmonary blood flow. A longer cardiopul-
onary bypass time (P  .02) and the need for postoperative extracorporeal membrane
xygenation support (P  .001) were associated with a higher mortality rate.
onclusions: With improved outcomes in the management of neonates with hypoplas-
ic left heart syndrome, those with the mitral stenosis–aortic atresia variant and left
entricle–subepicardial coronary artery fistulae have emerged as a higher-risk subgroup
or failure of stage I palliation. Further investigation is required, and a change in clinical
anagement strategy for this particular subgroup might be warranted.
ospital outcome after stage I surgical palliation for hypoplastic left heart
syndrome (HLHS) in our institution and others has improved considerably
in the last 2 decades (Figure 1).1,2 The decrease in overall hospital mortality
or these patients prompted a review of our more recent experience to investigate
hether there are specific anatomic subsets of patients who have not benefited from
his trend and might still be at increased risk. To date, few studies have looked at the
pecific anatomic variants of HLHS and their effect on surgical outcomes.1-4 Most
ublished studies have focused primarily on other factors, such as weight, prema-
urity, the size of the ascending aorta, or the relationship of left ventricular (LV) to
ight ventricular (RV) volumes.1-3
In a broader review of contemporary results for surgical palliation of HLHS, we
bserved worse early outcomes in the subset of patients with mitral stenosis–aortic
tresia (MS-AA) when compared with other anatomic variants (Figure 1). This
nding had been reported in previous studies but not specifically analyzed.3,5 In
atients with HLHS and anatomy consisting of MS-AA, previous angiographic and
athologic studies have described the presence of unique coronary artery anomalies,
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Ddentified as left ventricle–subepicardial coronary artery
ventriculocoronary) communications (left ventricle–coro-
ary artery [LV-CA] fistulae).6-8 In addition, it has also
een demonstrated that in this group of patients, there are
ore frequent abnormal pathologic findings within the ven-
ricle, such as myocardial necrosis, calcifications, and inter-
titial fibrosis.9
The purpose of this review is to summarize the recent
urgical outcomes for patients with HLHS and the MS-AA
ariant at our institution and to identify factors associated
ith hospital mortality and failure of stage I Norwood
alliation within this subgroup.
aterials and Methods
eview of medical records and computerized hospital data was
pproved by the Children’s Hospital Committee on Clinical In-
estigation (institutional review board), and the procedures fol-
Abbreviations and Acronyms
BDG  bidirectional Glenn
CPB  cardiopulmonary bypass
ECMO  extracorporeal membrane oxygenation
HLHS  hypoplastic left heart syndrome
IAS  intact or highly restrictive atrial septum
LV  left ventricular
LV-CA  left ventricle–coronary artery
mBTS modified Blalock–Taussig shunt
MS-AAmitral stenosis–aortic atresia
RV  right ventricular
RV-PA  right ventricle–pulmonary artery
SVR  Single Ventricle Reconstruction
igure 1. Hospital mortality for stage I palliation in HLHS during
he last 2 decades at the Children’s Hospital Boston. HLHS,
ypoplastic left heart syndrome; AA-Ms, aortic atresia–mitral
tenosis; AA-MA, aortic atresia–mitral atresia; AS-MS, aorticatenosis–mitral stenosis.
40 The Journal of Thoracic and Cardiovascular Surgery ● Febrowed were in accordance with institutional guidelines for retro-
pective record review and protection of patient confidentiality.
he need for patient consent was waived.
As part of a larger review of our contemporary outcomes of
tage I palliation for HLHS, we retrospectively identified and
ncluded in the study all infants with the diagnosis of HLHS and
S-AA who underwent stage I palliation at the Children’s Hos-
ital Boston between January 2001 and December 2006.
chocardiographic Evaluation
he anatomic diagnosis of the MS-AA variant of HLHS was
dentified by means of postnatal echocardiographic analysis in all
atients. A further retrospective review of the preoperative echo-
ardiogram was done in all 38 patients with MS-AA. All the
chocardiograms were independently reviewed by 2 cardiologists
n our institution, focusing on the status of the interatrial septum,
easurements of the mitral valve annulus, mitral valve function,
V end-diastolic volume, septal thickness, size of the ascending
orta, and presence of LV-CA fistulae. The echocardiographic
resence of LV-CA fistulae was defined as the presence of systolic
nd diastolic flow across the LV myocardium away from the mitral
alve orifice.10-13 In the last 3 patients in our series, we confirmed
he echocardiographic diagnosis of LV-CA fistulae with angio-
raphic analysis. The echocardiographic findings in these 3 cath-
terized patients with angiographically documented fistulae were
sed during the retrospective review of echocardiograms in the
emaining 35 patients with MS-AA (Figure 2).
The currently accepted definition of intact or highly restrictive
trial septum (IAS) was used as inclusion criteria for the definition
f this group of patients within our cohort of study14-16 and
ncluded patients for whom the following was the case: (1) the
trial septum is intact on either a prenatal or postnatal echocardio-
ram, (2) a prenatal echocardiogram showed a small atrial septal
efect with prominent pulmonary venous flow reversal, or (3) the
eonate had to be taken on an urgent or emergency basis to the
atheterization laboratory for left atrial decompression because of
linical signs of left atrial hypertension (severe hypoxia, hemody-
amic instability, or both).
urgical Procedure
ll patients were taken to the operating room after resuscitation
nd inotropic and ventilatory support, as necessary. Surgical in-
ervention consisted of standard stage I Norwood palliation with
eoaortic arch reconstruction and atrial septectomy. Pulmonary
lood flow was restored with either a modified Blalock–Taussig
hunt (mBTS) or a right ventricle–pulmonary artery (RV-PA)
onduit based on the individual surgeon’s preference and on ran-
omization in the ongoing Single Ventricle Reconstruction (SVR)
rial since January 2004. A period of deep hypothermic circulatory
rrest, selective antegrade cerebral perfusion, or both was used in
ll cases at the surgeon’s discretion.
tatistical Analysis
he primary outcome variables were failure of stage I palliation
defined as in-hospital mortality or need for heart transplantation)
nd interstage mortality occurring between stage I palliation and
idirectional Glenn (BDG) shunt. Patient and procedural variables
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Diagnosis, presence of intact or highly restrictive atrial septal
ommunication, anatomic subgroup, presence of coronary artery
stulae, degree of tricuspid valve regurgitation, age at surgical
ntervention, weight at surgical intervention, type of pulmonary
lood flow supply, need for revision of pulmonary blood flow
upply, cardiopulmonary bypass (CPB) time, circulatory arrest
ime, and postoperative extracorporeal membrane oxygenation
ECMO) requirement (Table 1). Continuous variables were sum-
arized as means  standard deviation or median (range). Char-
cteristics were compared for patients who died in the hospital
fter the stage I procedure versus those who survived until dis-
harge by using the Fisher exact test for categorical variables and
ither the 2-sample t test or the Wilcoxon rank sum test for
ontinuous variables. Patients with and without LV-CA fistulae
ere compared in a similar manner. Survival probabilities were
stimated by using the Kaplan–Meier method.
esults
emographics and Baseline Characteristics
rom January 2001 through December 2006, 38 neonates
25 male and 13 female neonates) with HLHS and the
S-AA anatomic subtype presented to our center and un-
erwent stage I palliation. There were no patients with this
iagnosis who died while awaiting surgical intervention
uring this study.
This group with MS-AA represents 23% (38/165) of all
eonates with HLHS presenting to our institution during the
ame period. Of these 38 patients comprising the study
roup, 21 (55%) were given prenatal diagnoses of HLHS.
wenty (53%) of the 38 patients had preoperative echocar-
iographic evidence of LV-CA fistulae. Of these 38 pa-
ients, 9 (26%) had an IAS and underwent creation or
nlargement of an atrial septal defect in the catheterization
ABLE 1. Variables associated with failed stage I palliati
Sur
ignificant variables
LV-CA fistulae, n (%)
Mean CPB time, n (SD)
Postoperative ECMO, n (%)
onsignificant variables
Prenatal diagnosis, n (%)
Prematurity, n (%)
Chromosomal anomalies, n (%)
Intact/highly restrictive AS, n (%)
Median age at surgical intervention, d (range)
Median weight, kg (range)
mBTS, n (%)
RV-PA conduit, n (%)
Mean CA time, n (SD)
Shunt revision, n (%)
V-CA, Left ventricle–coronary artery; CPB, cardiopulmonary bypass; ECM
lalock–Taussig shunt; RV-PA, right ventricle–pulmonary artery; CA, circula
ransplantation.aboratory before surgical intervention. a
The Journal of Thoracictage I Palliation
he 38 patients comprising the study group had stage I
alliation at a median of 4 days (range, 0 –36 days) of
ge, with a median weight of 3.1 kilograms (range,
.7– 4.4 kg). An mBTS supplied pulmonary blood flow in
3 (61%) patients, and its diameter was 3.5 mm in 20
atients, 4 mm in 1 patient (with IAS), and 3 mm in 2
atients who weighed less than 2 kg. When an RV-PA
onduit was placed, the conduit was constructed of either
4-mm (n  1) or 5-mm (n  14) Gore-Tex tube. The
nfant who received a 4-mm RV-PA conduit weighed less
han 2 kg. In 15 (40%) patients the source of pulmonary
lood flow had been randomized in the ongoing SVR trial
mBTS, 5; RV-PA conduit, 10).
Mean CPB time was 160  59 minutes, mean cross-
lamp time was 43  32 minutes, and mean circulatory
rrest time was 40 24 minutes. The chest was initially left
pen in 33 (87%) patients after surgical palliation and was
losed after a median of 3 days (range, 2–5 days).
Four (11%) of 38 patients required shunt revision (3 of
hese patients had an mBTS). Excessive pulmonary blood
ow prompted anatomic reduction of the shunt diameter in
patients, whereas acute shunt thrombosis occurred in 1
atient. In the remaining patient the RV-PA conduit was
hanged to an mBTS because of the finding of stenosis at
he proximal conduit anastomosis associated with a severely
hickened right ventricle.
Nine (24%) patients were supported postoperatively with
CMO; 6 of them died, and 2 underwent transplantation.
ndications for ECMO included inability to wean from CPB
n  3), severe RV dysfunction (n  3), cyanosis (n  2),
ortality/transplantation)
(n  27) Failed stage I (n  11)* P value
7) 10 (91) .004
 28 212 83 .01
) 8 (73) .001
2) 7 (64) .72
) 1 (9) 1.0
) 0 (0) 1.0
5) 5 (45) .12
–36) 4 (1–8) .79
–4.4) 3.1 (1.7–4.3) 1.0
6) 8 (73) 0.47
4) 3 (27) .47
 19 50  33 .18
) 3 (27) .13
xtracorporeal membrane oxygenation; AS, atrial septum; mBTS, modified
















torynd acute shunt thrombosis (n  1).
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Dospital Survival and Predictors of Mortality
ospital mortality and need for transplantation for patients
ith MS-AA was significantly higher than those for the
ther anatomic subgroups of patients with HLHS undergo-
ng stage I palliation during the same period (29% vs 7.9%,
 .002). Twenty-seven patients survived stage I pallia-
ion. Seven patients died from RV failure, 3 from sepsis, and
from alveolar capillary dysplasia. Two additional patients
nderwent orthotopic heart transplantation after stage I pal-
iation failed; 1 survived, and 1 did not. For the 27 hospital
urvivors to discharge, median hospital stay was 20 days
range, 4-82 days). The presence of LV-CA fistulae was
ssociated with failure of stage I palliation (P  .004).
ther variables significantly associated with hospital mor-
ality were longer CPB time (P  .02) and postoperative
CMO requirement (P  .001, Tables 1 and 2). Four
atients, all with LV-CA fistulae, required prolonged CPB
Figure 2. Echocardiographic (A), angiographic (B), and
ABLE 2. Variables associated with the presence of fistul
Y
ignificant variables
Failed stage I palliation, n (%)*
Mean CPB time, n (SD)
onsignificant variables
Prenatal diagnosis, n (%)
Prematurity, n (%)
Chromosomal anomalies, n (%)
Intact/highly restrictive AS, n (%)
Median age at surgical intervention, d (range)
Median weight, kg (range)
mBTS, n (%)
RV-PA conduit, n (%)
Mean CA time, n (SD)
Shunt revision, n (%)
Postoperative ECMO, n (%)
PB, Cardiopulmonary bypass; SD, standard deviation; AS, atrial septum; m
A, circulatory arrest; ECMO, extracorporeal membrane oxygenation. *Incfistulae. LV, Left ventricle; RV, right ventricle.
42 The Journal of Thoracic and Cardiovascular Surgery ● Febrssistance in the operating room because of multiple failed
ttempts of weaning; in 3 patients ECMO support was
tarted in the operating room. The presence of IAS or highly
estrictive atrial septum was not significantly associated
ith increased hospital mortality (P  .12) in patients with
S-AA.
nterstage and Midterm Survival
wenty-four (83%) of the 27 stage I survivors underwent a
DG procedure at a median of 138 days after stage I
alliation (range, 58–298 days). Interstage mortality oc-
urred in 1 (3%) patient. The cause of mortality was RV
ysfunction (this patient had an initial mBTS). This resulted
n an overall pre-BDG (hospital and interstage) mortality
ate of 31.5% (12/38 patients).
There was no hospital mortality associated with BDG
rocedures. One patient died 262 days after a BDG proce-
operative (C) images of left ventricle– coronary artery
Fistulae
 20, 53%) No (n  18, 47%) P value
(50)* 1 (6) .004
1 71 135  29 .01
(55) 10 (56) 1.0
(15) 0 (0) .23
(4) 0 (0) 1.0
(40) 2 (11) .07
(1–36) 4 (0–15) .69
(1.7–4.3) 3 (2–4.4) .91
(40) 7 (39) 1.0
(60) 11 (61) 1.0
2  28 37  19 .48
(15) 2 (11) 1.0
(35) 2 (11) .13
modified Blalock–Taussig shunt; RV-PA, right ventricle–pulmonary artery;
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Dure of RV failure. Two patients are still waiting for BDG
rocedures. At most recent follow-up, 14 patients had un-
ergone a fenestrated lateral tunnel Fontan operation at a
edian age of 31.3 months (range, 20.4–44.1 months).
urvival estimates according to the presence of LV-CA
stulae are shown in Figure 3.
iscussion
s with other large-volume centers, the hospital survival
fter stage I Norwood palliation for HLHS has dramatically
ncreased in our institution over the last 2 decades (Figure
). This improvement in survival can be attributed to a
umber of factors, including advances in perioperative and
perative strategies, as well as progress in transcatheter
echniques.
We undertook the current review in an attempt to deter-
ine specific survival rates and predictors of mortality in
ecent years. The overall hospital survival at the Children’s
ospital Boston after stage I palliation during the last 6
ears is 89% and is comparable with the recent published
ata in the literature.4,5,17,18 However, the risk of death and
ailure of stage I palliation is not homogenously distributed
cross the entire cohort of patients with HLHS, and patients
ith the MS-AA subtype and LV-CA fistulae had the high-
st risk of hospital mortality and failure of stage I palliation
P  .002).
In 1990, Murdison and colleagus19 reported that the
S-AA subgroup faired worse in the short and intermediate
erm after surgical palliation than other anatomic subgroups
f HLHS. Subsequently, Jonas and associates,3 in 1994,
peculated about a possible correlation between the diagno-
is of MS-AA and increased hospital mortality after stage I
alliation. Sugiyama and coworkers9 found that patients
igure 3. Kaplan–Maier survival estimates according to the pres-
nce of left ventricle– coronary artery fistulae (log–rank test for
quality of survival functions: P < .001).ith MS-AA had a thicker endocardium, and, histologi- n
The Journal of Thoracically, there were more abnormal findings, such as myocar-
ial necrosis, calcification, and interstitial fibrosis, com-
ared with other subtypes. These authors speculated that
hese findings were the result of relative coronary hypoper-
usion at the time of surgical intervention. Sauer and col-
eagues,8 in 1989, also reported a pathologic study demon-
trating the association of coronary artery anomalies in 42%
f the hearts of patients with HLHS and MS-AA. They
bserved that the hearts of these patients had a higher
ercentage of endocardial fibroelastosis, as well as thicker
nd more tortuous coronary arteries with an increased inti-
al thickness and stenosis, especially in the proximal left
oronary artery. This finding was suggestive of the presence
f anatomically significant fistulae. They theorized that
hese coronary abnormalities might impair ventricular
unction.
Our study demonstrated that patients with MS-AA had a
ignificantly higher mortality when compared with that of
ther patients with HLHS undergoing stage I palliation.
owever, on closer analysis, this increased risk appears to
e limited to patients with associated LV-CA fistulae. None
f the other studied variables were associated with signifi-
antly worse outcomes. In particular, the presence of IAS or
ighly restrictive atrial septum, although prevalent in this
ubgroup with MS-AA, was not related to hospital outcome
n our analysis. This might be due to the small number of
atients included in the study and will have to await con-
rmation by other studies.
The exact mechanisms for the increased rate of failure
fter stage I palliation in patients with MS-AA and fis-
ulae are still unclear. We hypothesize that the presence
f fistulae might interfere with adequate myocardial pro-
ection during CPB or might result in coronary hypoper-
usion once the heart is decompressed on CPB. The fact
hat many of the patients who died had problems begin-
ing in the operating room related to CPB (resulting in
ignificantly longer bypass times for the group that died)
ossibly suggests such a mechanism. However, those
ypotheses remain unproved.
In conclusion, the presence of LV-CA fistulae in patients
ith HLHS and MS-AA is a risk factor for increased
ospital mortality after surgical palliation. Patients with this
natomic variant of HLHS represent an identifiable sub-
roup that is at significantly increased risk. Based on these
ndings, we have changed the institutional policy for these
atients, performing preoperative angiography on all pa-
ients with MS-AA to confirm and better delineate the
V-CA fistulae. Further prospective evaluations with larger
umbers of patients are required to recommend modifica-
ion of the current surgical management of this anatomic
ariant of HLHS. Possible surgical alternatives include neo-
atal hybrid stage I palliation and heart transplantation.
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r Thomas L. Spray (Philadelphia, Pa). Although great im-
rovements in results for stage 1 Norwood procedures have been
chieved over the past decade, there continues to be a very sig-
ificant mortality with this procedure, and the cause of this early
ortality remains frustratingly obscure. Many centers have noted
igher mortality associated with certain anatomic and genetic risk
actors, such as aortic atresia, associated cardiac or noncardiac
nomalies, low birth weight, and so on, but this compelling study
dds a new and important risk group: patients with aortic atresia,
itral stenosis, and associated coronary fistulae from a small left
entricle. Although these patients represent a minority of the total
roup of patients with HLHS, they appear to be a major and,
erhaps in your series, the major source of mortality, at least in
oston.
Stimulated somewhat by this article, I went back and looked at
n experience from our own center over about a 3-year period
nding in May 2005 when we began the SVR trial randomization.
f 176 stage 1 operations in that 3-year period, our incidence of
ortic atresia/mitral stenosis was about 12%, and therefore a little
it less than what you saw in Boston in your own experience.
hen I got the comparison mortality data for all of those patients,
he overall survival was 92% in the patients without aortic atresia/
itral stenosis and 84% in those with aortic atresia/mitral stenosis.
lthough the numbers are very small, there were only 19 patients
ith aortic atresia/mitral stenosis, and that is probably not a
tatistically significant difference, or at least it leaves some cre-
ence to the finding that you have noted here.
Interestingly, though, at about a year, the overall survival rates
n the 2 groups were the same, and there was no interstage
ortality in the group with aortic atresia and mitral stenosis, which
gain is somewhat surprising.
I have several questions for the authors. First, are coronary
stulae limited to this subgroup, to the patients with aortic atresia/
itral stenosis? Do they occur if there is a small ventricular septal
efect or some other decompressing mode of the left ventricle?
pparently, they still do occur if you have mitral regurgitation, as
ou noted, which you would think would be a decompressing force
n the left ventricle.
How accurate is echocardiography in making this diagnosis?
re you looking for this in every patient? Do you ever see it in the
ther subgroups? How specific is this?
I must say that in our own center, our echocardiography folks
ccasionally mention this, but they do not seem to go to great
engths to try to look for these fistulae. I wonder, is that different
n Boston?
Dr Vida. Thank you very much for all your questions.
With regard to your first question, we did not study the pres-
nce of fistulae at the preoperative echocardiographic analysis in
ther subgroups of patient with HLHS. We reviewed a number of
athologic reports in the literature that demonstrated that the
resence of coronary fistula or left ventricle–coronary artery com-
unication was basically limited to patients with the aortic atresia/
itral stenosis variant of HLHS.
In response to your second question, we have considered the
resence of a ventricular septal defect as a possible differential
iagnosis in this group of patients because the fistulae are most
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Ds reported in the literature, the exact nature of the flow pattern in
he fistulae is a critical element of diagnostic accuracy. The flow in
he coronary fistulae was found to be from the ventricle to the
oronary artery in systole and from the coronary artery to the
entricle in diastole, and therefore there was to-and-fro flow across
he fistula. In the case of a ventricular septal defect, you can have
nly have flow going from the left ventricle to the right ventricle,
oth in systole and diastole.
With regard to the sensitivity of echocardiography as a diag-
osis tool, we were quite surprised to find that there was 92%
35/38 patients) consensus in the diagnosis of fistulae between the
separate senior echocardiographers who blindly reviewed the
reoperative echocardiographic studies of all the patients in our
tudy. Interestingly, one can make a comparison to the diagnosis of
stulae in patients with pulmonary atresia and intact ventricular
eptum, where echocardiography is 90% accurate in patients who
re later confirmed to have coronary fistulae by means of angio-
raphic analysis. In conclusion, we think that even though we
annot analyze the number, the magnitude, and the significance of
hese fistulae, we can diagnose their presence, and this was found
o be significantly related to a worse hospital outcome.
Dr Spray. You sort of lead into my second question with that
eference. Most of the mortality was early, early after surgical
ntervention in your series, and most of the deaths seemed to be
rom complications, to some extent, of RV dysfunction. I mean,
ven the sepsis is sort of related to a prolonged hospitalization,
uggesting that intraoperative events are causative of this poor
utcome.
Because the majority of these patients can be expected to have
right coronary–dominant coronary pattern based on previous
natomic studies of this subtype of patients and because in your
wn institution patients with pulmonary atresia and intact ventric-
lar septum and right ventricle–dependent coronary circulation do
ot seem to have such early ventricular dysfunction or dysfunction
t the time of shunt procedures or Fontan operations, do you think
here are potentially other anatomic features that might not have
een assessed here? The smaller aorta might not be effective, but
hat about tricuspid regurgitation? You did not mention that as
ne of the variables. What about preoperative RV dysfunction; was
hat present? That might account for some of these differences in
utcome.
Dr Vida. As discussed, we analyzed various anatomic vari-
bles in these patients without finding any significant difference
etween those patients with and without coronary fistulae. What
e found is that 7 of the 11 patients who died or had a failed stage
procedure had RV failure, and the possible mechanism of death
n these patients was myocardial ischemia. Five of the patients had
roblems being weaned off CPB, and 3 patients required ECMO
upport in the operating room.
We are now prospectively studying all patients with a diagnosis
f HLHS and aortic atresia/mitral stenosis who had an echocar-
iographic diagnosis of coronary fistulae with angiography to
nderstand whether there are other anatomic variables that we are
issing.
We have 5 patients who have a preoperative angiographic
onfirmation of coronary fistulae: 3 were included in this study,
nd 2 were not included because they did not have a traditional l
The Journal of Thoracictage I palliation but rather underwent a hybrid stage 1 procedure.
oth are alive and were discharged home.
We also reviewed the routine cardiac angiography that is per-
ormed before the BDG procedure. Only 8 patients had a left
entriculography, and in 2 of the 3 patients with the preoperative
iagnosis of coronary fistulae, there was complete regression of
hese fistulae. Therefore this again is something that needs to be
onsidered for further study.
Dr Spray. Did you do any posts on the patients who died? If
ou did, did you find any common mechanism or common pattern
f injury? Were these ventricular dysfunctions because of ischemic
amage?
Dr Vida. There were 4 patients who had an autopsy; 2 of them
re heart specimens obtained at the time of the transplantation. The
nly remarkable thing that we have found was the presence of
tresia of the left coronary ostium with aortocoronary discontinu-
tion in 1 patient. All the blood flow to the left coronary artery was
rovided by the huge fistula between the left ventricle and the left
oronary artery. In all the other patients, we found signs of isch-
mia with infarcted myocardium.
Dr Spray. I think this study should stimulate other centers to
o back and analyze their own patient groups. I think it is hopeful
hat data from the ongoing SVR trial, which is a randomized trial
ith a much larger multi-institutional patient population, will be
ble to separate out these characteristics and support these inter-
sting findings.
Dr Christian Pizarro (Wilmington, Del). That was a great
resentation.
What was the source of pulmonary blood flow in these pa-
ients? Were they evenly distributed between Blalock–Taussig
hunts and RV-PA conduct?
Dr Vida. The source of pulmonary blood flow was an mBTS in
3 patients and an RV-PA conduit in 15 patients. Before 2004, the
ource of pulmonary blood flow was chosen according to sur-
eon’s preference, whereas since January 2004, it has been ran-
omized according to the SVR trial.
Dr Pizarro. Did you observe any difference?
Dr Vida. No, there was no difference in hospital outcome
ccording to the type of pulmonary blood flow in this group of
atients.
Dr Pizarro. Not at all?
Dr Vida. No.
Dr Pizarro. How do you explain the difference in the length of
ypass between the patients who did well and the ones who did
ot? Did you change the shunt, or did you do anything about it?
Dr Vida. As previously discussed, 5 of the 11 patients who had
bad outcome needed to go back on bypass because of hemody-
amic instability and signs of myocardial ischemia characterized
y ST-segment changes at echocardiography. In 1 patient we had
o redo the Damus–Kaye–Stansel anastomosis because we thought
he problem was residual arch obstruction with possible coronary
nvolvement, but that was not the case. Therefore we believe that
he prolonged CPB times in patients who died or had a failed stage
procedure were due to myocardial ischemia after the surgical
alliation caused by the coronary fistulae.
Dr Pizarro. I would just caution you regarding your last
onclusion. In reference to the hybrid procedure, I think there is at
east anecdotal experience to suggest that the physiology of a
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Dybrid procedure is very similar to that in patients who undergo a
tage 1 Norwood procedure with a Blalock–Taussig shunt, and
herefore the problematic issue regarding coronary perfusion re-
ains. Although it is a lesser intervention, I think the physiology
s probably not as favorable.
Dr Vida. We believe that the main advantage of the hybrid
rocedure is the avoidance of the CPB and crossclamp times. The
voidance of myocardial ischemia might be a key point in explain-
ng the better outcome in certain patients in our series.
Dr Christian Brizard (Melbourne, Australia). I have 2 short
uestions.
I wonder whether you have demonstrated a difference of size in
he left ventricle and whether that would give a hint toward a left
nd right ventricle interaction in this group of patients.
Second, I understand that you have now a strategy to demon-
trate preoperatively coronary artery fistulae. If you do demon-
trate coronary fistulae, what do you do differently?
Dr Vida. With regard to your first question, one of the first
ariables we have analyzed in exploring the higher mortality in
his group of patients was the size of the left ventricle and its
nteraction with the motion of the ventricular septum. However,
e did not find any difference in size between patients with
stulae and those without fistulae. Again, there was no differ-
nce in the size of the left ventricle between those patients who
ied and those who survived the stage I palliation. In addition,
e tried to correlate the Z-score of the mitral valve with the
resence of fistulae, like comparing the Z-score of the tricuspid
alve and the presence of fistulae in patients with pulmonary a
46 The Journal of Thoracic and Cardiovascular Surgery ● Febrtresia and intact ventricular septum, but again, no relationship
as been found.
In response to your second question, we have a new policy in
ur institution to perform cardiac angiography, with LV injection
n all patients with preoperative echocardiographic diagnosis of
oronary fistulae. If the presence of fistulae is confirmed by means
f angiographic analysis, we now consider alternative management
trategies, such as the hybrid procedure and heart transplantation.
e have performed the hybrid procedure in 2 patients with these
haracteristics, and both were discharged home and are alive. The
ole of primary heart transplantation in these patients is still a
uch debated point.
Dr Emile A. Bacha (Boston, Mass). I have just a quick
ddendum to Dr Spray’s comment about what he found with the
hiladelphia patients. It is very important to point out that we
elieve that it is the fistulae per se that are the problem. If you do
ot look for the LV coronary fistulae, you might not really look at
he root of the problem. Aortic atresia/mitral stenosis alone in our
eries without fistulae was not tied with a higher mortality at all.
herefore if you have aortic atresia/mitral stenosis per se without
stulae, your survival is about the same, but if you have aortic
tresia/mitral stenosis with fistulae—and I would stress the point
hat you have to look for them—survival is worse. It is really
omething that one has to look for, either by means of echocar-
iographic analysis or by means of catheterization. Once we
tarted looking for them, it emerged as one of the risk factors,
uttressed by some of the pathology data that Vlad mentioned.
hat is a very important point not to be confused with just aortic
tresia/mitral stenosis alone.
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